Advances in Immunotherapeutic Approaches to Type 1 Diabetes

Int J Mol Sci. 2023 May 25;24(11):9220. doi: 10.3390/ijms24119220.

Abstract

Type 1 diabetes mellitus (T1D) is a multifactorial autoimmune disease characterized by the selective destruction of pancreatic insulin-producing beta cells due to the aberrant activation of different immune effector cells (reviewed (rev [...].

Publication types

  • Editorial

MeSH terms

  • Diabetes Mellitus, Type 1* / therapy
  • Humans
  • Immunotherapy
  • Insulin-Secreting Cells*